NeuroPace (NPCE) Debt to Equity (2020 - 2026)
NeuroPace has reported Debt to Equity over the past 7 years, most recently at $4.08 for Q1 2026.
- For Q1 2026, Debt to Equity rose 65.75% year-over-year to $4.08; the TTM value through Mar 2026 reached $4.08, up 65.75%, while the annual FY2025 figure was $3.09, 58.35% down from the prior year.
- Debt to Equity for Q1 2026 was $4.08 at NeuroPace, up from $3.09 in the prior quarter.
- Over five years, Debt to Equity peaked at $7.43 in Q4 2024 and troughed at $0.8 in Q1 2022.
- A 5-year average of $3.21 and a median of $3.02 in 2025 define the central range for Debt to Equity.
- Biggest five-year swings in Debt to Equity: soared 334.79% in 2022 and later crashed 58.35% in 2025.
- Year by year, Debt to Equity stood at $1.52 in 2022, then soared by 81.24% to $2.76 in 2023, then surged by 169.39% to $7.43 in 2024, then crashed by 58.35% to $3.09 in 2025, then skyrocketed by 31.97% to $4.08 in 2026.
- Business Quant data shows Debt to Equity for NPCE at $4.08 in Q1 2026, $3.09 in Q4 2025, and $3.17 in Q3 2025.